News
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. U.S. revenue was up 13% ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
Jefferies analysts note that FX was a significant headwind and it wasn’t quite clear the extent to which that had been ...
The AstraZeneca share price has been treading water for the past few years, but first-half results add strength to rising ...
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
Barclays today said half-year pre-tax profits rose 23% to £5.2 billion, boosted by a 28% improvement in the second quarter of ...
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
European stock markets are poised for a higher open on Tuesday, with major bourses looking to shake off the previous ...
DPA International on MSN3h
AstraZeneca reports profit jump in second quarter, confirms outlookProfit and revenue for British-Swedish drug major AstraZeneca were up in the second quarter, the company reported on Tuesday, ...
On a per-share basis, the Cambridge, Britain-based company said it had net income of 79 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The results met Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback